Skip to main content
SpringerLink
Log in

Modern Strategies for the Surgical Treatment of Priapism

  • Chapter
  • First Online:
Textbook of Male Genitourethral Reconstruction

  • 1923 Accesses

Abstract

Priapism, a prolonged penile erection unrelated to sexual stimulation, is a challenging urologic condition. Though amongst the most common urologic emergencies, priapism is a rare condition to encounter, and its pathophysiologic mechanisms remain poorly understood. If priapism is not diagnosed and treated appropriately and in a timely manner, there is a risk of progressive penile corporal fibrosis and eventual erectile dysfunction. In this chapter, we review the three distinct clinical presentations of priapism (ischemic, non-ischemic, and stuttering), and we describe concise and practical treatment algorithms for each based on the most recent and best quality scientific and clinical research. We hope that reading this chapter will not only streamline intervention for priapism but also stimulate further research into the pathophysiology of and potential therapies for priapism.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 109.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 139.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 199.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Eland IA, van der Lei J, Stricker BH, et al. Incidence of priapism in the general population. Urology. 2001;57:970–2.

    CAS  PubMed  Google Scholar 

  2. Roghmann F, Becker A, Sammon JD, et al. Incidence of priapism in emergency departments in the United States. J Urol. 2013;190:1275–80.

    PubMed  Google Scholar 

  3. Montague DK, Jarow J, Broderick GA, et al. American Urological Association guideline on the management of priapism. J Urol. 2003;170:1318–24.

    PubMed  Google Scholar 

  4. Salonia A, Eardley I, Giuliano F, et al. European Association of Urology guidelines on priapism. Eur Urol. 2014;65:480–9.

    PubMed  Google Scholar 

  5. Lue TF, Garcia M. Should perioperative anticoagulation be an integral part of the priapism shunting procedure? Transl Androl Urol. 2013;2:316.

    PubMed  PubMed Central  Google Scholar 

  6. Muneer A, Alnajjar HM, Ralph D. Recent advances in the management of priapism. F1000Res. 2018;7:37.

    PubMed  PubMed Central  Google Scholar 

  7. Reed-Maldonado AB, Kim JS, Lue TF. Avoiding complications: surgery for ischemic priapism. Transl Androl Urol. 2017;6:657–65.

    PubMed  PubMed Central  Google Scholar 

  8. Mwamukonda KB, Chi T, Shindel AW, et al. Androgen blockade for the treatment of high-flow priapism. J Sex Med. 2010;7:2532–7.

    CAS  PubMed  Google Scholar 

  9. Ridgley J, Raison N, Sheikh MI, et al. Ischaemic priapism: a clinical review. Turk J Urol. 2017;43(1):1–8.

    PubMed  PubMed Central  Google Scholar 

  10. Burnett AL, Anele UA, Trueheart IN, et al. Randomized controlled trial of sildenafil for preventing recurrent ischemic priapism in sickle cell disease. Am J Med. 2014;127:664–8.

    CAS  PubMed  PubMed Central  Google Scholar 

  11. Ralph DJ, Borley NC, Allen C, et al. The use of high-resolution magnetic resonance imaging in the management of patients presenting with priapism. BJU Int. 2010;106:1714–8.

    PubMed  Google Scholar 

  12. Shigehara K, Namiki M. Clinical management of priapism: a review. World J Mens Health. 2016;34(1):1–8.

    PubMed  PubMed Central  Google Scholar 

  13. Fowler JE Jr, Koshy M, Strub M, et al. Priapism associated with the sickle cell hemoglobinopathies: prevalence, natural history and sequelae. J Urol. 1991;145:65–8.

    PubMed  Google Scholar 

  14. Spycher MA, Hauri D. The ultrastructure of the erectile tissue in priapism. J Urol. 1986;135:142–7.

    CAS  PubMed  Google Scholar 

  15. Broderick GA, Kadioglu A, Bivalacqua TJ, et al. Priapism: pathogenesis, epidemiology, and management. J Sex Med. 2010;7:476–500.

    PubMed  Google Scholar 

  16. Warner MD, Peabody CA, Whiteford HA, et al. Trazodone and priapism. J Clin Psychiatry. 1987;48:244.

    CAS  PubMed  Google Scholar 

  17. Carson CC 3rd, Mino RD. Priapism associated with trazodone therapy. J Urol. 1988;139:369–70.

    PubMed  Google Scholar 

  18. Hanno PM, Lopez R, Wein AJ. Trazodone-induced priapism. Br J Urol. 1988;61:94.

    CAS  PubMed  Google Scholar 

  19. Eiland LS, Bell EA, Erramouspe J. Priapism associated with the use of stimulant medications and atomoxetine for attention-deficit/hyperactivity disorder in children. Ann Pharmacother. 2014;48:1350–5.

    CAS  PubMed  Google Scholar 

  20. Todd NV. Priapism in acute spinal cord injury. Spinal Cord. 2011;49:1033.

    CAS  PubMed  Google Scholar 

  21. Burnett AL, Bivalacqua TJ. Glucose-6-phosphate dehydrogenase deficiency: an etiology for idiopathic priapism? J Sex Med. 2008;5:237–40.

    CAS  PubMed  Google Scholar 

  22. Muneer A, Cellek S, Dogan A, et al. Investigation of cavernosal smooth muscle dysfunction in low flow priapism using an in vitro model. Int J Impot Res. 2005;17:10–8.

    CAS  PubMed  Google Scholar 

  23. Anele UA, Burnett AL. Erectile dysfunction after sickle cell disease-associated recurrent ischemic priapism: profile and risk factors. J Sex Med. 2015;12:713–9.

    PubMed  PubMed Central  Google Scholar 

  24. Kovac JR, Mak SK, Garcia MM, et al. A pathophysiology-based approach to the management of early priapism. Asian J Androl. 2013;15:20–6.

    PubMed  Google Scholar 

  25. Martin C, Cocchio C. Effect of phenylephrine and terbutaline on ischemic priapism: a retrospective review. Am J Emerg Med. 2016;34:222–4.

    PubMed  Google Scholar 

  26. Ebbehoj J. A new operation for priapism. Scand J Plast Reconstr Surg. 1974;8:241–2.

    CAS  PubMed  Google Scholar 

  27. Winter CC. Cure of idiopathic priapism: new procedure for creating fistula between glans penis and corpora cavernosa. Urology. 1976;8:389–91.

    CAS  PubMed  Google Scholar 

  28. Garcia MM, Shindel AW, Lue TF. T-shunt with or without tunnelling for prolonged ischaemic priapism. BJU Int. 2008;102:1754–64.

    PubMed  Google Scholar 

  29. Quackels R. Treatment of a case of priapism by Cavernospongious anastomosis. Acta Urol Belg. 1964;32:5.

    CAS  PubMed  Google Scholar 

  30. Sacher EC, Sayegh E, Frensilli F, et al. Cavernospongiosum shunt in the treatment of priapism. J Urol. 1972;108:97–100.

    CAS  PubMed  Google Scholar 

  31. Grayhack JT, McCullough W, O’Conor VJ Jr, et al. Venous Bypass to Control Priapism. Invest Urol. 1964;1:509.

    CAS  PubMed  Google Scholar 

  32. Barry JM. Priapism: treatment with corpus cavernosum to dorsal vein of penis shunts. J Urol. 1976;116:754–6.

    CAS  PubMed  Google Scholar 

  33. Burnett AL, Pierorazio PM. Corporal “snake” maneuver: corporoglanular shunt surgical modification for ischemic priapism. J Sex Med. 2009;6:1171–6.

    PubMed  Google Scholar 

  34. Segal RL, Readal N, Pierorazio PM, et al. Corporal Burnett “Snake” surgical maneuver for the treatment of ischemic priapism: long-term followup. J Urol. 2013;189:1025–9.

    PubMed  Google Scholar 

  35. Zacharakis E, Raheem AA, Freeman A, et al. The efficacy of the T-shunt procedure and intracavernous tunneling (snake maneuver) for refractory ischemic priapism. J Urol. 2014;191:164–8.

    PubMed  Google Scholar 

  36. Brant WO, Garcia MM, Bella AJ, et al. T-shaped shunt and intracavernous tunneling for prolonged ischemic priapism. J Urol. 2009;181:1699–705.

    PubMed  Google Scholar 

  37. Bennett N, Mulhall J. Sickle cell disease status and outcomes of African-American men presenting with priapism. J Sex Med. 2008;5:1244–50.

    PubMed  Google Scholar 

  38. Sedigh O, Rolle L, Negro CL, et al. Early insertion of inflatable prosthesis for intractable ischemic priapism: our experience and review of the literature. Int J Impot Res. 2011;23:158–64.

    CAS  PubMed  Google Scholar 

  39. Zacharakis E, Garaffa G, Raheem AA, et al. Penile prosthesis insertion in patients with refractory ischaemic priapism: early vs delayed implantation. BJU Int. 2014;114:576–81.

    PubMed  Google Scholar 

  40. Zacharakis E, De Luca F, Raheem AA, et al. Early insertion of a malleable penile prosthesis in ischaemic priapism allows later upsizing of the cylinders. Scand J Urol. 2015;1

    Google Scholar 

  41. Tausch TJ, Zhao LC, Morey AF, et al. Malleable penile prosthesis is a cost-effective treatment for refractory ischemic priapism. J Sex Med. 2015;12:824–6.

    PubMed  Google Scholar 

  42. Ralph DJ, Garaffa G, Muneer A, et al. The immediate insertion of a penile prosthesis for acute ischaemic priapism. Eur Urol. 2009;56:1033–8.

    PubMed  Google Scholar 

  43. Falcone M, Gillo A, Capece M, et al. The management of the acute ischemic priapism: a state of the art review. Actas Urol Esp. 2017;41:607.

    CAS  PubMed  Google Scholar 

  44. Salem EA, El Aasser O. Management of ischemic priapism by penile prosthesis insertion: prevention of distal erosion. J Urol. 2010;183:2300–3.

    PubMed  Google Scholar 

  45. Garcia M, Porten S, Lue TF. Commentary on refractory ischemic priapism. Transl Androl Urol. 2012;1:61.

    PubMed  PubMed Central  Google Scholar 

  46. Lutz A, Lacour S, Hellstrom W. Conversion of low-flow to high-flow priapism: a case report and review (CME). J Sex Med. 2012;9:951–4.

    PubMed  Google Scholar 

  47. Cahn D, Courter E, Diorio G, et al. Case report: conversion of a low-flow to high-flow priapism. Curr Urol. 2015;8:101.

    PubMed  PubMed Central  Google Scholar 

  48. Mistry NA, Tadros NN, Hedges JC. Conversion of low-flow priapism to high-flow state using T-shunt with tunneling. Case Rep Urol. 2017;2017:7394185.

    PubMed  PubMed Central  Google Scholar 

  49. Wu AK, Lue TF. Commentary on high flow, non-ischemic, priapism. Transl Androl Urol. 2012;1:109.

    PubMed  PubMed Central  Google Scholar 

  50. Brock G, Breza J, Lue TF, et al. High flow priapism: a spectrum of disease. J Urol. 1993;150:968–71.

    CAS  PubMed  Google Scholar 

  51. Zacharakis E, Ralph DJ, Walkden M, et al. Distal corpus cavernosum fibrosis and erectile dysfunction secondary to non-ischaemic priapism. Arch Ital Urol Androl. 2015;87:258–9.

    PubMed  Google Scholar 

  52. Reddy AG, Alzweri LM, Gabrielson AT, et al. Role of penile prosthesis in priapism: a review. World J Mens Health. 2018;36:4–14.

    PubMed  Google Scholar 

  53. Kim KR, Shin JH, Song HY, et al. Treatment of high-flow priapism with superselective transcatheter embolization in 27 patients: a multicenter study. J Vasc Interv Radiol. 2007;18:1222–6.

    PubMed  Google Scholar 

  54. Hakim LS, Kulaksizoglu H, Mulligan R, et al. Evolving concepts in the diagnosis and treatment of arterial high flow priapism. J Urol. 1996;155:541–8.

    CAS  PubMed  Google Scholar 

  55. Tan XZ, Liu Y, Guo YQ, et al. Post-traumatic high-flow priapism: multidetector computed tomography demonstration. Urology. 2015;86:e25–6.

    PubMed  Google Scholar 

  56. Tokue H, Shibuya K, Ueno H, et al. Percutaneous direct puncture embolization with N-butyl-cyanoacrylate for high-flow priapism. Cardiovasc Intervent Radiol. 2016;39:1343–6.

    PubMed  Google Scholar 

  57. Adeyoju AB, Olujohungbe AB, Morris J, et al. Priapism in sickle-cell disease; incidence, risk factors and complications - an international multicentre study. BJU Int. 2002;90:898–902.

    CAS  PubMed  Google Scholar 

  58. Cita KC, Brureau L, Lemonne N, et al. Men with sickle cell anemia and priapism exhibit increased hemolytic rate, decreased red blood cell deformability and increased red blood cell aggregate strength. PLoS One. 2016;11:e0154866.

    PubMed  PubMed Central  Google Scholar 

  59. Champion HC, Bivalacqua TJ, Takimoto E, et al. Phosphodiesterase-5A dysregulation in penile erectile tissue is a mechanism of priapism. Proc Natl Acad Sci U S A. 2005;102:1661–6.

    CAS  PubMed  PubMed Central  Google Scholar 

  60. Burnett AL, Lowenstein CJ, Bredt DS, et al. Nitric oxide: a physiologic mediator of penile erection. Science. 1992;257:401–3.

    CAS  PubMed  Google Scholar 

  61. Lagoda G, Sezen SF, Hurt KJ, et al. Sustained nitric oxide (NO)-releasing compound reverses dysregulated NO signal transduction in priapism. FASEB J. 2014;28:76–84.

    CAS  PubMed  PubMed Central  Google Scholar 

  62. Bivalacqua TJ, Musicki B, Hsu LL, et al. Sildenafil citrate-restored eNOS and PDE5 regulation in sickle cell mouse penis prevents priapism via control of oxidative/nitrosative stress. PLoS One. 2013;8:e68028.

    CAS  PubMed  PubMed Central  Google Scholar 

  63. Musicki B, Bivalacqua TJ, Champion HC, et al. Sildenafil promotes eNOS activation and inhibits NADPH oxidase in the transgenic sickle cell mouse penis. J Sex Med. 2014;11:424–30.

    CAS  PubMed  Google Scholar 

  64. Anele UA, Burnett AL. Nitrergic mechanisms for management of recurrent priapism. Sex Med Rev. 2015;3:160–8.

    PubMed  PubMed Central  Google Scholar 

  65. Lue TF. Erectile dysfunction. N Engl J Med. 2000;342:1802–13.

    CAS  PubMed  Google Scholar 

  66. Rajfer J, Aronson WJ, Bush PA, et al. Nitric oxide as a mediator of relaxation of the corpus cavernosum in response to nonadrenergic, noncholinergic neurotransmission. N Engl J Med. 1992;326:90–4.

    CAS  PubMed  Google Scholar 

  67. Corbin JD, Francis SH. Cyclic GMP phosphodiesterase-5: target of sildenafil. J Biol Chem. 1999;274:13729.

    CAS  PubMed  Google Scholar 

  68. Bivalacqua TJ, Musicki B, Kutlu O, et al. New insights into the pathophysiology of sickle cell disease-associated priapism. J Sex Med. 2012;9:79–87.

    CAS  PubMed  Google Scholar 

  69. Sopko NA, Matsui H, Hannan JL, et al. Subacute hemolysis in sickle cell mice causes priapism secondary to NO imbalance and PDE5 dysregulation. J Sex Med. 2015;12:1878–85.

    CAS  PubMed  PubMed Central  Google Scholar 

  70. Anele UA, Le BV, Resar LM, et al. How I treat priapism. Blood. 2015;125:3551–8.

    CAS  PubMed  PubMed Central  Google Scholar 

  71. Dai Y, Zhang Y, Phatarpekar P, et al. Adenosine signaling, priapism and novel therapies. J Sex Med. 2009;6(Suppl 3):292–301.

    CAS  PubMed  Google Scholar 

  72. Fu S, Davies KP. Opiorphin-dependent upregulation of CD73 (a key enzyme in the adenosine signaling pathway) in corporal smooth muscle cells exposed to hypoxic conditions and in corporal tissue in pre-priapic sickle cell mice. Int J Impot Res. 2015;27:140–5.

    CAS  PubMed  PubMed Central  Google Scholar 

  73. Ning C, Wen J, Zhang Y, et al. Excess adenosine A2B receptor signaling contributes to priapism through HIF-1alpha mediated reduction of PDE5 gene expression. FASEB J. 2014;28:2725–35.

    CAS  PubMed  PubMed Central  Google Scholar 

  74. Burnett AL, Bivalacqua TJ, Champion HC, et al. Feasibility of the use of phosphodiesterase type 5 inhibitors in a pharmacologic prevention program for recurrent priapism. J Sex Med. 2006;3:1077–84.

    CAS  PubMed  Google Scholar 

  75. Abern MR, Levine LA. Ketoconazole and prednisone to prevent recurrent ischemic priapism. J Urol. 2009;182:1401–6.

    CAS  PubMed  Google Scholar 

  76. Rachid-Filho D, Cavalcanti AG, Favorito LA, et al. Treatment of recurrent priapism in sickle cell anemia with finasteride: a new approach. Urology. 2009;74:1054–7.

    PubMed  Google Scholar 

  77. Hoeh MP, Levine LA. Prevention of recurrent ischemic priapism with ketoconazole: evolution of a treatment protocol and patient outcomes. J Sex Med. 2014;11:197–204.

    CAS  PubMed  Google Scholar 

  78. Burnett AL, Kan-Dobrosky N, Miller MG. Testosterone replacement with 1% testosterone gel and priapism: no definite risk relationship. J Sex Med. 2013;10:1151–61.

    CAS  PubMed  Google Scholar 

  79. Morrison BF, Anele UA, Reid ME, et al. Is testosterone deficiency a possible risk factor for priapism associated with sickle-cell disease? Int Urol Nephrol. 2015;47:47–52.

    CAS  PubMed  Google Scholar 

  80. Erdemir F, Firat F, Markoc F, et al. The effect of pentoxifylline on penile cavernosal tissues in ischemic priapism-induced rat model. Int Urol Nephrol. 2014;46:1961–7.

    CAS  PubMed  Google Scholar 

  81. Anele UA, Mack AK, Resar LM, et al. Hydroxyurea therapy for priapism prevention and erectile function recovery in sickle cell disease: a case report and review of the literature. Int Urol Nephrol. 2014;46:1733–6.

    CAS  PubMed  PubMed Central  Google Scholar 

  82. Machado RF, Barst RJ, Yovetich NA, et al. Hospitalization for pain in patients with sickle cell disease treated with sildenafil for elevated TRV and low exercise capacity. Blood. 2011;118:855–64.

    CAS  PubMed  PubMed Central  Google Scholar 

  83. Ellies M, Laskawi R, Tormahlen G, et al. The effect of local injection of botulinum toxin A on the parotid gland of the rat: an immunohistochemical and morphometric study. J Oral Maxillofac Surg. 2000;58:1251–6.

    CAS  PubMed  Google Scholar 

  84. Ellies M, Schutz S, Quondamatteo F, et al. Immunohistochemical investigations of the influence of botulinum toxin A on the immunoreactivity of nNOS in the parotid gland of the rat. J Oral Maxillofac Surg. 2006;64:397–401.

    PubMed  Google Scholar 

  85. Scott KR, Kothari MJ, Venkatesh YS, et al. Parotid gland injections of botulinum toxin a are effective in treating sialorrhea in amyotrophic lateral sclerosis. J Clin Neuromuscul Dis. 2005;7:62–5.

    PubMed  Google Scholar 

  86. Tighe D, Williams M, Howett D. Treatment of iatrogenic sialoceles and fistulas in the parotid gland with ultrasound-guided injection of botulinum toxin A. Br J Oral Maxillofac Surg. 2015;53:97–8.

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Urology Service, Madigan Army Medical Center, Tacoma, WA, USA

    Amanda B. Reed-Maldonado

  2. Department of Urology, University of California, San Francisco, San Francisco, CA, USA

    Tom F. Lue

Authors
  1. Amanda B. Reed-Maldonado
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Tom F. Lue
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Amanda B. Reed-Maldonado .

Editor information

Editors and Affiliations

  1. School of Medicine, University of Lisbon, Lisbon, Portugal

    Francisco E. Martins

  2. Kulkarni Reconstructive Urology Center, Pune, India

    Sanjay B. Kulkarni

  3. Department of Urology, Mayo Clinic, Rochester, MN, USA

    Tobias S. Köhler

Rights and permissions

Reprints and permissions

Copyright information

© 2020 Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Reed-Maldonado, A.B., Lue, T.F. (2020). Modern Strategies for the Surgical Treatment of Priapism. In: Martins, F.E., Kulkarni, S.B., Köhler, T.S. (eds) Textbook of Male Genitourethral Reconstruction. Springer, Cham. https://doi.org/10.1007/978-3-030-21447-0_42

Download citation

  • DOI: https://doi.org/10.1007/978-3-030-21447-0_42

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-030-21446-3

  • Online ISBN: 978-3-030-21447-0

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation